Francisco Manuel
Martín Bermudo
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (6)
2024
-
Novel insights into metabolic-associated steatotic liver disease preclinical models
Liver International, Vol. 44, Núm. 3, pp. 644-662
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2021
-
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
Frontiers in Immunology, Vol. 12
2018
-
miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation
Molecular Therapy - Nucleic Acids, Vol. 12, pp. 463-477
2014
-
GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice
Hepatology, Vol. 59, Núm. 6, pp. 2358-2370